BillionToOne Inc. (BLLN)
BillionToOne Inc. (BLLN) Stock Price, Analysis & Data
| Precio de compra | 66.51 |
| Capitalización de mercado | 4.33B |
| Ingresos (TTM) | 397.41M |
| Beneficio neto (TTM) | 33.18M |
| Beta | n/a |
| EPS (TTM) | 0.74 |
| Ratio PER (TTM) | 123.88 |
| Adelante PE | 68.92 |
| P/B (TTM) | 8.00 |
| P/S (TTM) | 10.88 |
| Earnings Date | Nov 5, 2026 |
| Precio de venta | 115.2 |
| Volumen | 529,861 |
| Volumen medio (20D) | 765,896 |
| Abierto | 89.87 |
| Anterior Cerrar | 87.99 |
| Rango del día | 89.19 - 94.25 |
| Rango de 52 semanas | 61.96 - 150.44 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de BLLN
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Norths...
Desempeño financiero
En 2025, los ingresos de BillionToOne fueron 305.11M, un aumento de undefined% en comparación con n/a del año anterior. Las ganancias fueron 7.45M, un aumento de undefined%.
Estados financierosSorpresa de resultados
Los analistas proyectan ingresos de ... Actualizar
1 semana hace · Simply Wall St.
Can BillionToOne (BLLN) Justify Its Price On Earnings And Reaffirmed 2026 Guidance?BillionToOne (BLLN) is back in focus after its August 5 update, when the company reported second quarter 2026 results and reaffirmed its full-year revenue outlook in the mid US$400 million range. See ...
